Describe the differences between hepatitis A, B, and C, including ...

[kodithompson]

Describe the differences between hepatitis A, B, and C, including their methods of transmission, clinical manifestations, and modes of treatment.

Question 2

A RD initiates a calorie count on a patient; however, she expects to be on vacation when the calorie count is to be tallied. In her chart note, she decides to include her estimate of the patient's energy needs so that the covering RD does not have to recalculate these. This RD's purpose or reason for writing the energy needs is an example of which of the following aspects of writing?
 a. Functions of writing
  b. Writing processes
  c. Levels of discourse
  d. Rhetorical norms of writing

[ms_sulzle]

Answer to Question 1

Hepatitis is an inflammation of the liver caused by a virus, bacteria, toxins, obstruction, parasites, or chemicals. Hepatitis A is generally transmitted via the oral-fecal route. Sources of contamination include drinking water, food, and sewage. Symptoms are typically nausea, vomiting and fatigue. There are no special treatments for hepatitis A except rest, adequate nutrition, and fluids. Hepatitis B (HBV) is transmitted through transfusions of blood or through improperly sterilized medical instruments or other skin-puncturing instruments that have come in contact with contaminated blood. Acute hepatitis B virus infection is a short-term illness, much like HAV infection. Chronic hepatitis B may cause cirrhosis or liver cancer. For acute infection, no medication is available; treatment is supportive, much like that for HAV. For chronic infection, two oral medications, tenofovir and entecavir, and an injected drug, pegylated interferon, are considered first-line options. Hepatitis C (HCV) transmission occurs when an individual is exposed to blood or body fluids from an infected person. Hepatitis C is often asymptomatic but may cause jaundice, abdominal pain, dark urine, and fatigue. The therapy for chronic hepatitis C has become more effective over the 10 years since alpha interferon was first approved for use. Recently, a new oral, non-interferon medication, sofosbuvir, was approved by the FDA for the treatment of chronic hepatitis C.

Answer to Question 2

d

[kodithompson]

TY

[ms_sulzle]

You're welcome